Drugmaker BioLineRx Beats Investor Suit Over Cash Shortfall

By Katryna Perera · July 16, 2024, 7:00 PM EDT

Israeli biotech company BioLineRx has, for now, beaten a proposed class action over claims that it misled investors on its capital shortfall, which caused a major decline in its share price,...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

IN RE BIOLINERX LTD. SECURITIES LITIGATION

Case Number

2:23-cv-00041

Court

New Jersey

Nature of Suit

Securities/Commodities

Date Filed

January 05, 2023